Detecting cognitive impairment in patients with Parkinsons disease using a brief cognitive screening tool: Addenbrookes Cognitive Examination (ACE).
|Autores||Chade AR, Roca M, Torralva T, Gleichgerrcht E, Fabbro N, Gómez Arévalo G, Gershanik O, Manes F.|
|Journal||Chade AR, Roca M, Torralva T, Gleichgerrcht E, Fabbro N, Gómez Arévalo G, Gershanik O, Manes F.|
|Abstract||Detecting cognitive impairment in patients with Parkinson´s disease is crucial for good clinical practice given the new therapeutic possibilities available. When full neuropsychological evaluations are not available, screening tools capable of detecting cognitive difficulties become crucial. Objective: The goal of this study was to investigate whether the Spanish version of the Addenbrooke´s Cognitive Examination (ACE) is capable of detecting cognitive difficulties in patients with Parkinson´s disease and discriminating their cognitive profile from patients with dementia. Methods: 77 early dementia patients (53 with Alzheimer´s Disease and 24 with Frontotemporal Dementia), 22 patients with Parkinson´s disease, and 53 healthy controls were evaluated with the ACE. Results: Parkinson´s disease patients significantly differed from both healthy controls and dementia patients on ACE total score. Conclusions: This study shows that the Spanish version of the ACE is capable of detecting patients with cognitive impairment in Parkinson´s disease and is able to differentiate them from patients with dementia based on their general cognitive status.|